Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Sacubitril/Valsartan (LCZ696) – Bringing yet another advantage through innovative API offerings

Our team of process and analytical experts draw on their integrated understanding in both the development and manufacturing of the API and the formulation. This is of particular importance when it comes to the characterization of a molecular complex which is critical for a successful API and formulation development. This holistic view, also helps to better understand the impact of the formulation process on the molecular integrity and stability of the product. As a result, our development of this supra molecular complex, was able to robustly match the characteristics of the reference listed drug (RLD).

Read our latest whitepaper on this topic by filling the contact form below.

You can also explore our Sacubitril/Valsartan (LCZ696) offering by clicking on the link below:

https://api.drreddys.com/product/sacubitril-valsartan

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Email us: api@drreddys.com | +91 40 49002222

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.